Herbalife (HLF) Aktievy
Herbalife Ltd., tillsammans med sina dotterbolag, tillhandahåller hälso- och friskvårdsprodukter i Nordamerika, Mexiko, Syd- och Centralamerika, Europa, Mellanöstern, Afrika, Kina och Asien/Stillahavsområdet. Mer information
| Snöflinga Score | |
|---|---|
| Värdering | 5/6 |
| Framtida tillväxt | 3/6 |
| Tidigare resultat | 0/6 |
| Finansiell hälsa | 0/6 |
| Utdelningar | 0/6 |
Belöningar
Riskanalys
HLF Community Fair Values
Create NarrativeSee what 26 others think this stock is worth. Follow their fair value or set your own to get alerts.
Analyst Price Targets
Herbalife Ltd. Konkurrenter
Prishistorik och prestanda
| Historiska aktiekurser | |
|---|---|
| Aktuell aktiekurs | US$12.65 |
| 52 veckors högsta | US$20.40 |
| 52 veckors lägsta | US$7.56 |
| Beta | 0.88 |
| 1 månads förändring | 6.39% |
| 3 månaders förändring | 4.37% |
| 1 års förändring | 33.72% |
| 3 års förändring | -18.23% |
| 5 års förändring | -75.28% |
| Förändring sedan börsintroduktionen | 243.75% |
Senaste nyheter och uppdateringar
Seeking Alpha • Aug 17
Herbalife Ltd.: The Share Price Is Discounting Terminal Decline
Summary Herbalife Ltd. is rated a 'risky' Buy, with shares trading at a steep discount and the market pricing in an overly pessimistic perpetual decline. HLF posted four consecutive quarters of YoY net sales growth, driven mainly by a one-off India GST cut, while other regions showed mixed or declining volume trends. Strategic repositioning toward personalized nutrition and deleveraging efforts are underway, with net leverage reduced to 2.2x and $45M in annual cash interest savings unlocked. Despite risks from GLP-1 adoption, growth concentration, leverage, and regulatory exposure, the current price offers potential upside versus a base case fair value near $24. Read the full article on Seeking AlphaAnalysartikel • Aug 08
Herbalife Ltd. Just Missed Earnings With A Surprise Loss - Here Are Analysts Latest Forecasts
Herbalife Ltd. ( NYSE:HLF ) came out with its second-quarter results last week, and we wanted to see how the business...
Uppdatering av berättelse • Aug 07
HLF: 2026 Guidance Execution And Margin Expansion Will Support Share Recovery
Analysts have trimmed their price target on Herbalife to $17 from $21, reflecting updated views on fair value, discount rate, revenue growth, profit margins and future P/E assumptions. What’s in the News for Herbalife Herbalife raised its full year 2026 net sales guidance to a range of 2.5% to 5.5% year over year, compared with its previous range of 1.5% to 5.5% year over year.Recent updates
Seeking Alpha • Aug 17
Herbalife Ltd.: The Share Price Is Discounting Terminal Decline
Summary Herbalife Ltd. is rated a 'risky' Buy, with shares trading at a steep discount and the market pricing in an overly pessimistic perpetual decline. HLF posted four consecutive quarters of YoY net sales growth, driven mainly by a one-off India GST cut, while other regions showed mixed or declining volume trends. Strategic repositioning toward personalized nutrition and deleveraging efforts are underway, with net leverage reduced to 2.2x and $45M in annual cash interest savings unlocked. Despite risks from GLP-1 adoption, growth concentration, leverage, and regulatory exposure, the current price offers potential upside versus a base case fair value near $24. Read the full article on Seeking AlphaAnalysartikel • Aug 08
Herbalife Ltd. Just Missed Earnings With A Surprise Loss - Here Are Analysts Latest Forecasts
Herbalife Ltd. ( NYSE:HLF ) came out with its second-quarter results last week, and we wanted to see how the business...Uppdatering av berättelse • Aug 07
HLF: 2026 Guidance Execution And Margin Expansion Will Support Share Recovery
Analysts have trimmed their price target on Herbalife to $17 from $21, reflecting updated views on fair value, discount rate, revenue growth, profit margins and future P/E assumptions. What’s in the News for Herbalife Herbalife raised its full year 2026 net sales guidance to a range of 2.5% to 5.5% year over year, compared with its previous range of 1.5% to 5.5% year over year.Uppdatering av berättelse • Jun 18
HLF: Execution On 2026 Guidance And Margins Will Drive Stock Rebound
Analysts have lifted their price target on Herbalife to about $18.33 from $17.50, citing updated assumptions around discount rates, expected revenue growth, profit margins, and future P/E multiples reflected in recent research. Analyst Commentary Recent research on Herbalife highlights a mix of optimism around execution and valuation, alongside ongoing caution about the company’s ability to sustain and convert growth assumptions into consistent earnings.
Uppdatering av berättelse • Jun 03
HLF: Refinancing And Margin Improvement Will Support Turnaround Despite Weak EBITDA Guidance
Narrative update on Herbalife Analysts have raised their price target on Herbalife by $2, citing research that points to updated assumptions around discount rates, revenue growth, profit margins, and future P/E expectations. Analyst Commentary Bullish analysts raising their price target by US$2 are signaling a more constructive view on how Herbalife’s valuation lines up with its fundamentals.Analysartikel • May 19
Investors Can Find Comfort In Herbalife's (NYSE:HLF) Earnings Quality
Investors were disappointed with the weak earnings posted by Herbalife Ltd. ( NYSE:HLF ). However, our analysis...Uppdatering av berättelse • May 05
HLF: Mixed 2026 Guidance And Execution Outlook Will Shape Turnaround Prospects
Herbalife's analyst price target has been revised higher to $17.50 from $16.50, with analysts pointing to updated fair value assumptions and recent target increases at firms such as Citi, BofA and Mizuho following Q4 results and 2026 guidance. Analyst Commentary Recent research updates show a mix of optimism and caution around Herbalife, with price targets moving in different directions as analysts react to Q4 results, 2026 guidance and updated assumptions around execution and valuation.Uppdatering av berättelse • Apr 20
HLF: 2026 Guidance And Margin Recovery Will Drive Turnaround Momentum
Analysts lifted their price targets for Herbalife by as much as $4, with some pointing to Q4 results that were largely in line, fresh 2026 guidance, and what they view as stronger recent momentum as key factors behind the adjustment. Analyst Commentary Bullish analysts are highlighting recent price target increases on Herbalife as a sign of improving confidence in the story, especially after Q4 results that were described as largely in line and supported by new 2026 guidance.Uppdatering av berättelse • Apr 06
HLF: Turnaround Momentum And Q1 2026 Outlook Will Support Margin Recovery
Herbalife's updated analyst price target has moved from $14.00 to $16.50 as analysts factor in recent target increases, slightly higher projected revenue growth and margins, and a modestly lower discount rate, alongside updated views on valuation multiples. Analyst Commentary Recent research views on Herbalife show a mix of optimism about a potential turnaround and caution about the broader sector and the company’s fundamentals.
Uppdatering av berättelse • Mar 23
HLF: 2026 Turnaround Ambitions Will Face Ongoing Competitive And Fundamental Pressures
Herbalife's analyst price target has shifted toward $9.00, with recent research citing Q4 results viewed as solid by some firms, new 2026 guidance, and mixed views on valuation and competitive pressures. Some analysts also commented that regulatory concerns in the U.S. are considered resolved and the business model more sustainable.Uppdatering av berättelse • Mar 09
HLF: 2026 Turnaround Hopes Will Confront Persistent Competitive And Fundamental Risks
The analyst price target for Herbalife has been raised by $1 to $9. Analysts point to largely in line Q4 results, new 2026 guidance, and a mix of Buy, Neutral, and Underperform views that reflect both perceived momentum and ongoing concerns around competition, fundamentals, and valuation.Uppdatering av berättelse • Feb 23
HLF: Turnaround Will Be Driven By 2026 Guidance And Margin Recovery
Narrative Update: Herbalife The updated analyst fair value estimate for Herbalife has moved from $11 to $25, a shift analysts link to refreshed price targets in the $9 to $21 range, stronger Q4 commentary, improved margin assumptions, and a lower discount rate despite mixed views on long term growth and valuation risks. Analyst Commentary Recent Street research on Herbalife reflects a mix of views, but several bullish analysts have been willing to raise price targets or upgrade their stance following recent updates from the company.Uppdatering av berättelse • Feb 08
HLF: Turnaround Hopes Under New Leadership Will Confront Compressed Sector Multiples
Narrative Update: Herbalife Analyst Price Target Move The blended analyst price target for Herbalife has moved higher, with recent increases such as Mizuho's lift to $13 and Maxim's initiation at $20. Analysts point to an ongoing turnaround, progress under new leadership, and a healthier long term profile for Herbalife's business model, while also noting continuing concerns about competition and broader macro uncertainty.Uppdatering av berättelse • Jan 25
HLF: Recovery Story Under New Leadership Will Face Compressed Sector Multiples
Narrative Update on Herbalife The analyst price target for Herbalife has been revised higher to reflect an updated fair value of $8.00, a lower discount rate of 10.02%, and adjustments to revenue growth, profit margin, and future P/E assumptions, as analysts factor in recent target hikes, Buy initiations, and views of a continuing recovery path under new leadership. Analyst Commentary Recent Street research on Herbalife reflects a mix of optimism about a potential recovery and caution around execution and valuation risks.Analysartikel • Jan 22
Herbalife Ltd. (NYSE:HLF) Shares Fly 27% But Investors Aren't Buying For Growth
Herbalife Ltd. ( NYSE:HLF ) shares have continued their recent momentum with a 27% gain in the last month alone. The...Uppdatering av berättelse • Jan 11
HLF: Turnaround And Margin Recovery Under New Leadership Will Face Valuation Constraints
The analyst price target on Herbalife in our model has moved from US$12 to US$14, as analysts point to a recovery path supported by a healthier profit margin outlook, a slightly lower discount rate, and recent research highlighting ongoing business model improvements despite tempered revenue growth expectations and cautious sector valuations. Analyst Commentary Recent research on Herbalife reflects a mix of optimism about the company’s turnaround efforts and caution about broader sector and macro headwinds.Uppdatering av berättelse • Dec 25
HLF: Recovery Path Under New Leadership Will Likely Deliver Disappointing Multiple Expansion
Analysts have modestly raised their fair value estimate for Herbalife from approximately $9.67 to $12.00 per share, citing a lower perceived risk profile, steady growth and margin assumptions, and a more constructive view on future earnings multiples as fundamentals continue on a recovery path under new leadership. Analyst Commentary Analyst sentiment around Herbalife is gradually improving as execution under new leadership gains traction and forward growth expectations firm up, though views on the pace and durability of the recovery remain mixed.Uppdatering av berättelse • Dec 11
HLF: Recovery Path Under New Leadership Will Likely Prove Overpriced
Analysts have modestly raised their price target on Herbalife to $11 from $10, citing a gradually lower perceived risk profile, steady long term growth and margin assumptions, and growing confidence that the company is on a recovery path under new leadership, with a potential return to volume growth by fiscal 2026. Analyst Commentary Bullish analysts point to the recent rating upgrade and price target increase as evidence that sentiment around Herbalife is gradually improving, with expectations that operational execution will support a more favorable risk and reward profile over the next several years.Uppdatering av berättelse • Nov 27
HLF: Uncertainty Around CEO Transition Will Challenge Near-Term Momentum
Herbalife’s analyst price target has been raised to $11 from $10, as analysts point to recovering fundamentals and the company’s strategic leadership changes as promising signs for future growth. Analyst Commentary Analysts have recently weighed in on Herbalife, offering a mix of optimism about its improving fundamentals and some caution about ongoing risks.Analysartikel • Nov 13
We Think That There Are Some Issues For Herbalife (NYSE:HLF) Beyond Its Promising Earnings
The market for Herbalife Ltd.'s ( NYSE:HLF ) stock was strong after it released a healthy earnings report last week...Analysartikel • Oct 29
The Market Doesn't Like What It Sees From Herbalife Ltd.'s (NYSE:HLF) Earnings Yet
When close to half the companies in the United States have price-to-earnings ratios (or "P/E's") above 19x, you may...Analysartikel • Sep 26
At US$8.75, Is Herbalife Ltd. (NYSE:HLF) Worth Looking At Closely?
Herbalife Ltd. ( NYSE:HLF ), might not be a large cap stock, but it saw a decent share price growth of 11% on the NYSE...Analysartikel • Jul 24
A Look At The Intrinsic Value Of Herbalife Ltd. (NYSE:HLF)
Key Insights The projected fair value for Herbalife is US$9.20 based on 2 Stage Free Cash Flow to Equity Herbalife's...Analysartikel • Jun 25
There's No Escaping Herbalife Ltd.'s (NYSE:HLF) Muted Earnings Despite A 26% Share Price Rise
Those holding Herbalife Ltd. ( NYSE:HLF ) shares would be relieved that the share price has rebounded 26% in the last...Analysartikel • May 28
Herbalife (NYSE:HLF) Hasn't Managed To Accelerate Its Returns
If we want to find a stock that could multiply over the long term, what are the underlying trends we should look for...Analysartikel • May 08
Herbalife's (NYSE:HLF) Earnings Offer More Than Meets The Eye
Herbalife Ltd.'s ( NYSE:HLF ) solid earnings announcement recently didn't do much to the stock price. We did some...Analysartikel • Mar 13
Herbalife Ltd.'s (NYSE:HLF) Share Price Boosted 63% But Its Business Prospects Need A Lift Too
Herbalife Ltd. ( NYSE:HLF ) shares have had a really impressive month, gaining 63% after a shaky period beforehand. But...Seeking Alpha • Feb 24
Herbalife: The Battleground Stock Is Showing Some Turnaround Potential
Summary Herbalife still operates in 95 countries using a direct selling and MLM model with six million independent distributors. Currently, HLF is facing declining sales volumes, which have been partly offset by price increases. However, it remains uncertain how sustainable this is in the long run. Post-FTC settlement, I think HLF has “sanitized” its business model, even though it has indeed made it more challenging to grow its MLM business. The good news is its focus. They have a mixed regional performance, in particular with China struggling while Asia Pacific stabilizes. Additionally, its recruitment and sales leaders numbers have been encouraging in Q4 and 2024. Based on EV/EBITDA metrics, HLF is undeniably still priced at a steep discount. However, at this point, I believe the risk-reward equation is more favorable for the bulls. Hence, I rate it a speculative “Buy” for the short term. Read the full article on Seeking AlphaAktieägarnas avkastning
| HLF | US Personal Products | US Marknad | |
|---|---|---|---|
| 7D | 5.5% | 9.0% | -1.2% |
| 1Y | 33.7% | -6.1% | 18.3% |
Avkastning vs industri: HLF översteg US Personal Products branschen som gav -6.1 % under det senaste året.
Avkastning vs Marknaden: HLF översteg US marknaden som gav 18.3 % under det senaste året.
Prisvolatilitet
| HLF volatility | |
|---|---|
| HLF Average Weekly Movement | 6.8% |
| Personal Products Industry Average Movement | 9.8% |
| Market Average Movement | 7.2% |
| 10% most volatile stocks in US Market | 16.4% |
| 10% least volatile stocks in US Market | 3.1% |
Stabil aktiekurs: HLF har inte haft någon betydande prisvolatilitet under de senaste 3 månaderna jämfört med marknaden för US.
Volatilitet över tid: HLF s veckovolatilitet ( 7% ) har varit stabil under det senaste året.
Om företaget
| Grundad | Anställda | VD OCH KONCERNCHEF | Webbplats |
|---|---|---|---|
| 1980 | 8,500 | Stephan Gratziani | www.herbalife.com |
Herbalife Ltd., tillsammans med sina dotterbolag, tillhandahåller hälso- och friskvårdsprodukter i Nordamerika, Mexiko, Syd- och Centralamerika, Europa, Mellanöstern, Afrika, Kina och Asien och Stillahavsområdet. Företaget erbjuder produkter för viktkontroll, inklusive måltidsersättning, proteinshakes, dryckesblandningar, viktminskningstillskott, hälsosamma snacks och teer som ökar ämnesomsättningen; produkter för målinriktad näring som omfattar funktionella drycker och kost- och näringstillskott som innehåller örter, vitaminer, mineraler och andra naturliga ingredienser; energi-, sport- och fitnessprodukter; samt produkter för hudvård, kroppsvård och hårvård. Företaget tillhandahåller också litteratur, reklammaterial och annat material, t.ex. startpaket, säljverktyg och utbildningsmaterial.
Herbalife Ltd. Sammanfattning av grunderna
| HLF grundläggande statistik | |
|---|---|
| Börsvärde | US$1.33b |
| Vinst(TTM) | US$164.20m |
| Intäkter(TTM) | US$5.20b |
8.1x
P/E-förhållande0.3x
P/S-förhållandeÄr HLF övervärderat?
Se Verkligt värde och värderingsanalysResultat & intäkter
| HLF resultaträkning (TTM) | |
|---|---|
| Intäkter | US$5.20b |
| Kostnad för intäkter | US$1.16b |
| Bruttovinst | US$4.04b |
| Övriga kostnader | US$3.88b |
| Intäkter | US$164.20m |
Senast redovisade vinst
Jun 30, 2026
Nästa vinstdatum
n/a
| Vinst per aktie (EPS) | 1.57 |
| Bruttomarginal | 77.70% |
| Nettovinstmarginal | 3.16% |
| Skuld/egenkapitalförhållande | -431.7% |
Hur har HLF utvecklats på lång sikt?
Se historisk utveckling och jämförelseFöretagsanalys och finansiella data Status
| Uppgifter | Senast uppdaterad (UTC-tid) |
|---|---|
| Analys av företag | 2026/08/24 05:05 |
| Aktiekurs vid dagens slut | 2026/08/21 00:00 |
| Intäkter | 2026/06/30 |
| Årlig intjäning | 2025/12/31 |
Datakällor
Den data som används i vår företagsanalys kommer från S&P Global Market Intelligence LLC. Följande data används i vår analysmodell för att generera denna rapport. Data är normaliserade vilket kan medföra en fördröjning från det att källan är tillgänglig.
| Paket | Uppgifter | Tidsram | Exempel US-källa |
|---|---|---|---|
| Företagets finansiella ställning | 10 år |
| |
| Analytikernas konsensusuppskattningar | +3 år |
|
|
| Marknadspriser | 30 år |
| |
| Ägarskap | 10 år |
| |
| Förvaltning | 10 år |
| |
| Viktiga utvecklingstendenser | 10 år |
|
* Exempel för amerikanska värdepapper, för icke-amerikanska värdepapper används motsvarande regelverk och källor.
Om inget annat anges är all finansiell data baserad på en årsperiod men uppdateras kvartalsvis. Detta kallas data för efterföljande tolv månader (TTM) eller senaste tolv månader (LTM). Lär dig mer om detta.
Analysmodell och snöflinga
Detaljer om analysmodellen som används för att skapa den här rapporten finns på vår Github-sida, vi har också guider om hur du använder våra rapporter och handledningar på Youtube.
Lär dig mer om det team i världsklass som utformade och byggde analysmodellen Simply Wall St.
Industri- och sektormått
Våra bransch- och sektionsmått beräknas var sjätte timme av Simply Wall St, detaljer om vår process finns tillgängliga på Github.
Källor för analytiker
Herbalife Ltd. bevakas av 14 analytiker. 3 av dessa analytiker lämnade de uppskattningar av intäkter eller resultat som användes som indata till vår rapport. Analytikernas inskickade estimat uppdateras löpande under dagen.
| Analytiker | Institution |
|---|---|
| John Staszak | Argus Research Company |
| Meredith Adler | Barclays |
| Brian Wang | Barclays |